News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
126,360 Results
Type
Article (4255)
Company Profile (94)
Press Release (122011)
Section
Business (42040)
Career Advice (207)
Deals (6150)
Drug Delivery (14)
Drug Development (17391)
Employer Resources (18)
FDA (1485)
Job Trends (2770)
News (66131)
Policy (3641)
Tag
Academia (287)
Alliances (11362)
Alzheimer's disease (270)
Approvals (1473)
Artificial intelligence (22)
Bankruptcy (37)
Best Places to Work (2224)
Biotechnology (89)
Breast cancer (34)
Cancer (264)
Career advice (195)
CAR-T (24)
Cell therapy (94)
Clinical research (13589)
Collaboration (118)
Compensation (35)
COVID-19 (413)
C-suite (45)
Cystic fibrosis (19)
Data (304)
Diabetes (22)
Diagnostics (663)
Drug discovery (25)
Earnings (12145)
Employer resources (18)
Events (23920)
Executive appointments (116)
FDA (1582)
Funding (94)
Gene therapy (46)
GLP-1 (94)
Government (338)
Healthcare (1489)
Infectious disease (428)
Inflammatory bowel disease (39)
Interviews (17)
IPO (2881)
Job creations (665)
Job search strategy (184)
Layoffs (33)
Legal (633)
Manufacturing (49)
Medical device (389)
Medtech (389)
Mergers & acquisitions (3341)
Metabolic disorders (63)
Neuroscience (334)
NextGen Class of 2024 (853)
Non-profit (267)
Northern California (465)
Obesity (34)
Opinion (37)
Parkinson's disease (19)
Patents (27)
People (16066)
Phase I (5386)
Phase II (6481)
Phase III (3338)
Pipeline (132)
Policy (22)
Postmarket research (209)
Preclinical (2330)
Press Release (51)
Radiopharmaceuticals (44)
Rare diseases (41)
Real estate (1439)
Regulatory (2834)
Research institute (296)
Resumes & cover letters (20)
Southern California (436)
Startups (980)
United States (3601)
Vaccines (51)
Weight loss (18)
Date
Today (34)
Last 7 days (221)
Last 30 days (1024)
Last 365 days (9176)
2024 (8429)
2023 (9880)
2022 (11995)
2021 (12643)
2020 (9849)
2019 (6672)
2018 (5278)
2017 (6080)
2016 (5593)
2015 (6439)
2014 (4922)
2013 (4060)
2012 (4397)
2011 (4870)
2010 (4514)
Location
Africa (135)
Alabama (19)
Asia (8328)
Australia (1951)
California (1053)
Canada (348)
China (58)
Connecticut (33)
Europe (18026)
Florida (90)
Illinois (88)
Indiana (57)
Maryland (119)
Massachusetts (741)
Michigan (50)
Minnesota (65)
New Jersey (264)
New York (252)
North Carolina (178)
Northern California (465)
Ohio (26)
Pennsylvania (231)
South America (198)
Southern California (436)
Texas (105)
Washington State (218)
126,360 Results for "adverum biotechnologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Adverum Biotechnologies, Inc. today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in a fireside chat at TD Cowen’s Genetic Medicines & RNA Summit on Friday, June 21, 2024 at 10:00 a.m. ET.
June 18, 2024
·
1 min read
Press Releases
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 20, 2024
November 21, 2024
·
1 min read
Biotech Bay
Adverum Biotechnologies to Participate in Upcoming May 2024 Investor Conferences
Adverum Biotechnologies, Inc., a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, announced that the company will present at the following upcoming investor conferences.
May 3, 2024
·
1 min read
Press Releases
Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
November 4, 2024
·
8 min read
Business
Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences
September 4, 2024
·
1 min read
Business
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
Adverum Biotechnologies, Inc., a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, reported financial results for the first quarter of 2024.
May 9, 2024
·
9 min read
Press Releases
Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
November 18, 2024
·
15 min read
Press Releases
Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program
October 17, 2024
·
6 min read
Business
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
Adverum Biotechnologies, Inc. announced the appointments of Dr. Rabia Gurses Ozden to the Company’s executive leadership team as chief medical officer and Dr. Szilárd Kiss to the Company’s Board of Directors.
June 11, 2024
·
7 min read
Press Releases
Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
November 18, 2024
·
3 min read
1 of 12,636
Next
